Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;119(8):837-840.
doi: 10.1007/s00347-021-01462-w. Epub 2021 Jul 28.

[Conjunctival mantle cell lymphoma-a therapeutic challenge]

[Article in German]
Affiliations

[Conjunctival mantle cell lymphoma-a therapeutic challenge]

[Article in German]
André M Trouvain et al. Ophthalmologie. 2022 Aug.
No abstract available

PubMed Disclaimer

References

Literatur

    1. Abrahamsson A, Albertsson-Lindblad A, Brown PN, Baumgartner-Wennerholm S, Pedersen LM, D’Amore F, Nilsson-Ehle H, Jensen P, Pedersen M, Geisler CH, Jerkeman M (2014) Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study. Blood 124(8):1288–1295. https://doi.org/10.1182/blood-2014-03-559930 - DOI - PubMed
    1. Amstutz CA, Michel S, Thiel MA (2004) Follicular conjunctivitis caused by a mantle cell lymphoma. Klin Monbl Augenheilkd 221(5):398–400. https://doi.org/10.1055/s-2004-812865 - DOI - PubMed
    1. Auw-Hädrich C, Reinhard T (2019) Konjunktivale Malignome. Ophthalmologe 116(10):989–1004. https://doi.org/10.1007/s00347-019-00978-6 - DOI - PubMed
    1. Ferrer A, Salaverria I, Bosch F, Villamor N, Rozman M, Beà S, Giné E, López-Guillermo A, Campo E, Montserrat E (2007) Leukemic involvement is a common feature in mantle cell lymphoma. Cancer 109(12):2473–2480. https://doi.org/10.1002/cncr.22715 - DOI - PubMed
    1. Hermine O, Hoster E, Walewski J et al (2016) Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet 388(10044):565–575. https://doi.org/10.1016/S0140-6736(16)00739-X - DOI - PubMed